Product Reports Resources Pricing Login Book a demo

Oncomfort

Health Tech & Medtech · Wavre, Belgium · Founded 2017

Virtual reality digital sedation for medical procedures MoreLess

Oncomfort was a Belgian-based developer of a digital sedation device for managing patient pain and anxiety before, during, and after medical procedures. Founded in 2017 by Diane Jooris, Mario Huyghe, and Julien Tesse, the company created a non-pharmacological therapy that combines clinical hypnosis and integrative therapeutic techniques using virtual reality. This approach aimed to reduce the need for medications and improve patient comfort and outcomes.

Co-founder Diane Jooris, who served as Chief Scientific Officer, has a background in clinical psychology and law, and practiced clinical hypnosis at the MD Anderson Cancer Center. Her experience helping cancer patients manage anxiety during invasive procedures inspired her to develop a more scalable, automated tool for hypnotherapy. Co-founder Mario Huyghe, who acted as CEO, has over two decades of experience in the healthcare business and eHealth sectors.

The company's core product, the Sedakit™, was a portable, all-in-one medical device that included a VR headset and provided a library of therapeutic sessions tailored to different patient needs, ages, and medical contexts, available in 12 languages. It was designed for use in various clinical fields, including anesthesia, oncology, interventional radiology, cardiology, and pediatrics. Clinical studies indicated that the digital sedation method could reduce procedure times, decrease involuntary movements, and in 80% of certain orthopedic surgeries, replace the sedative drug midazolam.

In September 2020, Oncomfort secured a €10 million ($11.8M) Series A funding round co-led by Debiopharm and Crédit Mutuel Innovation to advance product development and accelerate international expansion into European and American markets. The company gained a CE mark for its device in June 2018 and, by late 2020, had treated over 60,000 patients. In October 2023, Oncomfort was acquired by HypnoVR, a French competitor in the VR-based medical hypnosis space. The acquisition was intended to consolidate HypnoVR's market leadership in Europe and ensure the continued development and availability of Oncomfort's technology, which is now integrated into HypnoVR's offerings.

Keywords: digital sedation, virtual reality therapy, non-pharmacological pain relief, medical hypnosis, patient anxiety management, VR medical device, clinical hypnosis, digital therapeutics, medtech, pain management, anxiety relief, surgical support, interventional radiology, oncology patient support, pediatric sedation, non-invasive therapy, alternative to sedation, therapeutic VR, healthcare innovation, medical device

Company overview

Oncomfort company information

The essential company record, classifications and operating signals in one place.

Status
Acquired
Founded
2017
Headquarters
Wavre, Belgium
Employees
1
Open positions
None listed
Dealroom signal
59.1
client focusb2btechnologyDeep TechtechnologyVirtual Realitysub industryMedical Devicessub industryHealth Platformbusiness modelManufacturingsectorPsychologyindustryHealthsectorData AnalyticssectorBiotechnologysectorMental HealthsectorImmersive TechnologiessectorDigital TherapeuticssectorTech for Biotech and Pharma

Valuation & funding

Oncomfort funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITIONExit Oct 2023 $0 Hypno VR
SERIES AEquity / VC Sep 2020 $11M $44M WE Venture · Crédit Mutuel Innovation · Debiopharm Group · Crédit Mutuel Equity
SEEDEquity / VC Sep 2018 $1.9M $7.5M BAN Flanders · WE Venture · Be Angels
SEEDEquity / VC Apr 2017 $1.1M $4.3M Undisclosed
Showing 4 recorded eventsUnlock the complete deal history →

Financials

Revenue, earnings and profit over time

Reported history and available estimates. Estimated years are marked “E”; sparse fields are left blank rather than inferred.

YearEBITDAMarginProfitMargin
2026 −$1.4M −$1.8M
2025 −$1.4M −$1.8M
2024 −$1.4M −$1.8M
2023 −$1.4M
2022 −$1.4M
2021 −$1.4M
2020 −$1.1M
Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

Oncomfort website traffic

Latest recorded traffic for Oncomfort is 50 monthly website visits, down 95.8% over the last three months. Oncomfort's team declined 75% over the past year.

Latest monthly visits50 3-month web change-95.8% 1-year team growth-75%
Monthly website visits83 observations · Oct 2017–Mar 2025
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Oncomfort compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

Oncomfort's talent

Book a demo to see the people
Team profiled 6 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

8 investors on Oncomfort's cap table

Sourced from Dealroom's funding and investor records.

Seed 3 investors entered at this stage
Be Angels
BAN Flanders
WE Venture
Series A 3 investors entered at this stage
Crédit Mutuel Innovation
Debiopharm Group
Crédit Mutuel Equity
Other known 2 additional known investors
Hypno VR
Caring Entrepreneurship Fund

Global footprint

Where Oncomfort has talent and traffic

Workforce by country
1 countries with
team presence
🇧🇪 Belgium100%
1 country shown

In the news

Latest news about Oncomfort

Recent press, funding announcements, and product moves mentioning Oncomfort — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Oncomfort

An AI-synthesized read of the highest-engagement posts about Oncomfort on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Oncomfort’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.